The Integration of Real World Evidence Analytics in Modern Pharma In the landscape of 2026, the success of a new therapeutic agent is increasingly dictated by the depth of real world evidence analytics applied during the pre-launch phase. Commercial pharmaceutical insights have shifted from traditional survey-based models to longitudinal data streams that capture patient outcomes in diverse...

As the healthcare community grapples with the challenges of antibiotic resistance, the future of the sector is becoming clearer. The Antibiotic Resistance Market Forecast indicates promising growth, with expectations of a CAGR of 3.59% through 2032. This trajectory reflects a heightened awareness of antibiotic misuse and the urgent need for new solutions, setting the stage for...